AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MORNIFLUMATE

8 registrations across 3 African markets— 7 active

Markets with MORNIFLUMATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
NIFLURIL 700MG SUPPOSITOIRE BOITE DE 8🇨🇮Côte d'IvoireUPSA SASexpiredFeb 2026
NIFLURIL AD 700MG SUP(8) UPSA SAS
suppositoire Adulte 700mg (8)
🇲🇬MadagascarUPSA SASactive
NIFLURIL ENFANTS 400MG SUP SEC(8) UPSA SAS
suppositoire Enfant 400mg
🇲🇬MadagascarUPSA SASactive
NIFLURIL
suppositoire / 400 mg
🇸🇳SenegalUPSAactive
NIFLURIL
suppositoire / 400 mg
🇸🇳SenegalUPSAactive
NIFLURIL ENFANTS 400 MG SUPPOSITOIRE SÉCABLE BOÎTE DE 8🇨🇮Côte d'IvoireLABORATOIRE UPSA SASactive
NIFLURIL AD 700MG SUP(8) UPSA SAS
suppositoire Adulte 700mg (8)
🇲🇬MadagascarUPSA SASactive
NIFLURIL ENFANTS 400MG SUP SEC(8) UPSA SAS
suppositoire Enfant 400mg
🇲🇬MadagascarUPSA SASactive

MORNIFLUMATE in Africa — Regulatory Overview

MORNIFLUMATE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.